Agios Stock Down Year: Why It Fell 16% and What Next
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Understand the key steps to create a successful retirement plan. Set yourself up for a financially secure future.
21,515 articlesBiotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Two researchers are launching a dedicated effort to bring sustainability back into the AI conversation, promising mea...
The Bank of Korea is moving its CBDC pilot into a second phase, linking deposit tokens to live bank accounts to test ...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
Warren Buffett’s long run outperformed the market for 60 years, driven by durable moats and patient capital. Learn th...
As AI infrastructure expands, storage demand soars. This article lays out a grounded path for Sandisk's stock by 2027...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
If SpaceX ever files for an IPO, the prospectus would reveal the core drivers, the risks, and the questions investors...
As AI accelerates, a pair of blue-chip picks stands out for a decade-long hold. Learn why these two AI leaders fit th...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...